COVID-19 Adult Vaccines
Closed Solicitation Posted
- Solicitation number
- 75D30124R72942
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) is seeking to award one or more indefinite delivery indefinite quantity (IDIQ) contracts for the purchase of standard adult vaccines, including COVID-19 vaccines. The CDC is seeking vaccines with a Biologic License Application (BLA) or Emergency Use Authorization (EUA) from the FDA, with a minimum order of 100 doses and a maximum of 30 million doses. The contracts will have a one-year ordering period, and offers will be evaluated based on technical capability, price, and past performance. The CDC intends to use Section 317 vaccine purchase funds to obtain the vaccines at prices below the commercial market.
This procurement is not set aside for any specific business category. The main NAICS code is 325412 (Pharmaceutical Preparation Manufacturing), and the PSC code is 6505 (Drugs, Biological and Official Reagents). There are no incumbent contractors identified, and the CDC has not provided a budget range. The place of performance is the United States, with specific delivery locations in Olive Branch, MS, Aurora, CO, and/or Clermont, KY.
Notice text
The Centers for Disease Control and Prevention (CDC) is seeking to award one or more indefinite delivery indefinite quantity (IDIQ) contracts for the purchase of standard adult vaccines.
Item Description and Quantities
Covid-19 Vaccine - Adult (Age 19 years and older)
Maximum ordering quantity: Up to 30 million doses
Minimum ordering quantity: 100 doses
Minimum order size: 100 doses
Federal Excise Tax: $0.75 per dose
Ordering period: One year from date of award
The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial market place In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.
Offers shall be submitted by 4:30PM Easter time (EST) on April 17, 2024. Offers shall be submitted electronically (via email) in Microsoft Word and/or Microsoft Excel files to Matthew Nelson, Contract Specialist, lza0@cdc.gov and David Dombeck, Contracting Officer, vwj8@cdc.gov. Offers shall reference RFP No. 75D30124R72942.
This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.SAM.gov when issued. No hard copies of the solicitation and amendments will be mailed.
Inquiries about the solicitation shall be submitted to Matthew Nelson, Contract Specialist, at lza0@cdc.gov. The deadline for questions to be submitted prior to the due date for proposals is April 12, 2024 at 4:30PM EST. The Government may not answer questions received after this date.
Files
| File | Type | Posted |
|---|---|---|
| Amendment 2 to RFP 75D30124R72942.docx | DOCX document | |
| Amendment 1 to RFP 75D30124R72942.docx | DOCX document | |
| RFP 75D30124R72942 COVID19 Adult Vaccines.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity